Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues FN Q1 2026 Earnings EPS Beats Estimates Surprise of 147 QDEL Q1 2026 Earnings Severe EPS Miss Amidst Revenue Uncertainty MCD Q1 2026 Earnings EPS Slightly Above Estimates Amid Modest Stock Decline PRTC Q4 2024 Earnings EPS Misses Estimates as Stock Holds Steady AUR Q1 2026 Earnings Narrower Loss Surprises Market as Autonomous Truck Developer Progresses